Loader

Pathways

PathWhiz ID Pathway Meta Data

PW145408

Pw145408 View Pathway
drug action

Bezafibrate Drug Metabolism Action Pathway

Homo sapiens

PW128405

Pw128405 View Pathway
drug action

Bezitramide Opioid Agonist Action Pathway

Homo sapiens
Bezitramide is a narcotic analgesic that has been withdrawn due to overdoses. It is taken orally with a long duration of action. Bezitramide binds to opioid receptors, stimulating the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as GABA is inhibited. Opioids close N-type voltage-operated calcium channels and open calcium-dependent inwardly rectifying potassium channels. This results in hyperpolarization and reduced neuronal excitability. Morphine acts at A delta and C pain fibres in the dorsal horn of the spinal cord. By decreasing neurotransmitter action there is less pain transmittance into the spinal cord. This leads to less pain perception.

PW123995

Pw123995 View Pathway
metabolic

BHMT

Felinus

PW132489

Pw132489 View Pathway
metabolic

Bicalutamide Drug Metabolism

Homo sapiens
Bicalutamide is a drug that is not metabolized by the human body as determined by current research and biotransformer analysis. Bicalutamide passes through the liver and is then excreted from the body mainly through the kidney.

PW145217

Pw145217 View Pathway
drug action

Bicalutamide Drug Metabolism Action Pathway

Homo sapiens

PW146277

Pw146277 View Pathway
drug action

Bicisate Drug Metabolism Action Pathway

Homo sapiens

PW127482

Pw127482 View Pathway
drug action

Bictegravir Action Pathway

Homo sapiens
Bictegravir is an integrase inhibitor used to treat HIV-1 and HIV-2 infections. Bictegravir is indicated in the management of HIV-1 infection in patients not previously treated with antiretroviral therapy. Additionally, Bictegravir is indicated in the management of HIV-1 infection in patients who are virologically suppressed (HIV-1 RNA <50 c/mL) on a regular antiretroviral regimen for a minimum of three months without a history of failure in treatment and no known factors associated with the resistance to the individual components of the medication. In vitro, bictegravir has shown powerful antiviral activity against HIV-2 and various subtypes of HIV-1. It is used in combination with tenofovir and emtricitabine. Bictegravir is transported into the infected cell then transported into the nucleus via importin nuclear transporter. The viral RNA is injected into the cell then transcribed into viral DNA via reverse transcriptase. It is then transported into the nucleus where it is integrated into the host DNA. Bictegravir inhibits HIV integrase which prevents the viral DNA from being integrated into the host DNA. This prevents viral replication and further progression of the virus. It is used in combination with reverse transcriptase inhibitors which further prevents viral replication and progression of the virus.

PW146452

Pw146452 View Pathway
drug action

Bictegravir Drug Metabolism Action Pathway

Homo sapiens

PW126970

Pw126970 View Pathway
drug action

Bifonazole Action Pathway

Homo sapiens
Bifonazole is an azole anti-fungal drug used to treat fungal skin infections, such as dermatomycosis and athlete's foot. It comes as a cream which is spread on the infected skin. Bifonazole inhibits lanosterol 14-alpha demethylase in the endoplasmic reticulum of fungal cells. Lanosterol 14-alpha demethylase is the enzyme that catalyzes the synthesis of 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol from lanosterol. With this enzyme inhibited ergosterol synthesis cannot occur which causes a significant low concentration of ergosterol in the fungal cell. Ergosterol is essential in maintaining membrane integrity in fungi. Without ergosterol, the fungus cell cannot synthesize membranes thereby increasing fluidity and preventing growth of new cells. This leads to cell lysis which causes it to collapse and die.

PW145571

Pw145571 View Pathway
drug action

Bifonazole Drug Metabolism Action Pathway

Homo sapiens